Intervention Study on Medication Reconciliation Among Pharmacists in Two Tertiary Hospitals in Nigeria

This study will assess the current practice of medication reconciliation among pharmacists in the selected institutions with a view to making an intervention to address gaps discovered

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Intervention Study Cardiovascular Diseases Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Hypertension Metabolic Diseases Nutritional and Metabolic Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Ilorin Teaching Hospital, Ilorin, Kwara State, Nigeria

About this study

Background information garnering will be done among the pharmacists in the two selected hospitals to collect data on current practice of medication reconciliation. Focus group discussion will be done in the intervention group so as to identify peculiarities of their practice and to provide the best approach to carrying out the intervention. Diabetes and hypertensive patients in medical outpatient clinic will be interviewed in order to assess current practice of medication reconciliation.

Intervention will be channeled towards addressing gaps discovered. University College Hospital, Ibadan, Oyo State will be the intervention group, while University of Ilorin Teaching Hospital, Kwara State will be the control group.

The effect of the intervention will be measured over time to ensure that medication reconciliation is implemented in the selected institutions.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Participant has diabetes and/or hypertension
Registered pharmacists in the selected institutions

Exclusion criteria

Participants that are neither diabetic nor hypertensive
Unregistered pharmacists in the selected institutions

Treatment and study plan

Medication reconciliation

Other

Pre-post intervention

Primary outcomes

Medication reconciliation: Percentage unreconciled medications

Time frame: 3 months

Percentage unreconciled medications

Sponsors and collaborators

Lead sponsor

University of Ibadan

Other

Registry information

Important dates

Study start: 2016
Primary completion: 2019
Study completion: 2019
First posted: Jun 9, 2017
Registry last updated: Nov 30, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed